$SMMT.US Ranked Positive On March 28th, 2024
Summit Therapeutic (SMMT US, +1, 28-Mar-24) Ankur Dhingra (CFO since 2022) purchased $375,000 of stock on the 26th of March at $3.75, increasing his stake by 39%. This is much his largest purchase or subscription and also much the highest price he has paid. His only previous clean purchase was for $44,000 of stock at $2.17 and it’s […]